# Long Term Follow-up for RGX-202

> **NCT06491927** · — · ENROLLING_BY_INVITATION · sponsor: **REGENXBIO Inc.** · enrollment: 66 (estimated)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **GENETIC:** No Intervention

## Key facts

- **NCT ID:** NCT06491927
- **Lead sponsor:** REGENXBIO Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-05-08
- **Primary completion:** 2029-12-01
- **Final completion:** 2029-12-01
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06491927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06491927, "Long Term Follow-up for RGX-202". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06491927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*